After Ferrostatin-1 treatment, the S100-induced autoimmune hepatitis group had significantly lower ALT, AST, and IgG levels compared with the S100-induced autoimmune hepatitis model group (P < 0.05). This evidence concerns the gene GPT and autoimmune hepatitis.